Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Bright Health Group Inc. | 84,164,844 | reported | 28 Jun 2021 | tx 22+135,584,859−56,632,637 |
| TAPIMMUNE INC | 10,714,285 | reported | 16 Mar 2021 | tx 1+5,714,285 |
| GENOCEA BIOSCIENCES, INC. | 10,376,936 | reported | 24 Jul 2020 | tx 5+21,594,998 |
| Regulus Therapeutics Inc. | 6,451,056 | reported | 04 Dec 2020 | tx 8+24,903,571 |
| Achaogen Inc | 5,215,128 | reported | 19 Dec 2016 | tx 1+500,000 |
| AVEO PHARMACEUTICALS INC | 3,952,958 | reported | 19 Jun 2020 | tx 29+20,657,569 |
| ARDELYX, INC. | 3,482,186 | reported | 09 Dec 2019 | tx 7+3,760,634 |
| Monte Rosa Therapeutics, Inc. | 2,715,968 | reported | 28 Jun 2021 | tx 7+7,692,298−23,450,637 |
| Akouos, Inc. | 2,505,996 | reported | 30 Jun 2020 | tx 7+4,294,207−3,705,972 |
| Inozyme Pharma, Inc. | 2,000,533 | reported | 28 Jul 2020 | tx 5+2,437,689−2,187,689 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Oct 2022 | GRANT_AWARD | Eargo, Inc. | 74,074 | 0.00 USD | deriv |
| 23 Aug 2022 | GRANT_AWARD | Eargo, Inc. | 74,805 | 0.00 USD | deriv |
| 28 Jun 2021 | CONVERSION | Bright Health Group Inc. | 3,673,284 | — | |
| 28 Jun 2021 | PURCHASE | Bright Health Group Inc. | 250,000 | 18.00 USD | |
| 28 Jun 2021 | CONVERSION | Bright Health Group Inc. | 14,942,061 | — | |
| 28 Jun 2021 | CONVERSION | Bright Health Group Inc. | 7,346,568 | — | |
| 28 Jun 2021 | PURCHASE | Bright Health Group Inc. | 1,694,444 | 18.00 USD | |
| 28 Jun 2021 | CONVERSION | Bright Health Group Inc. | 10,601,925 | — | |
| 28 Jun 2021 | CONVERSION | Bright Health Group Inc. | 26,703,498 | — | |
| 28 Jun 2021 | CONVERSION | Bright Health Group Inc. | 19,549,068 | — | |
| 28 Jun 2021 | CONVERSION | Bright Health Group Inc. | 3,327,852 | — | |
| 28 Jun 2021 | CONVERSION | Bright Health Group Inc. | 3,494,244 | — | |
| 28 Jun 2021 | CONVERSION | Bright Health Group Inc. | 5,864,718 | — | |
| 28 Jun 2021 | CONVERSION | Bright Health Group Inc. | 38,137,197 | — | |
| 28 Jun 2021 | CONVERSION | Bright Health Group Inc. | 1,224,428 | 0.00 USD | deriv |
| 28 Jun 2021 | CONVERSION | Bright Health Group Inc. | 4,980,687 | 0.00 USD | deriv |
| 28 Jun 2021 | CONVERSION | Bright Health Group Inc. | 12,712,399 | 0.00 USD | deriv |
| 28 Jun 2021 | CONVERSION | Bright Health Group Inc. | 1,164,748 | 0.00 USD | deriv |
| 28 Jun 2021 | CONVERSION | Bright Health Group Inc. | 2,448,856 | 0.00 USD | deriv |
| 28 Jun 2021 | CONVERSION | Bright Health Group Inc. | 1,954,906 | 0.00 USD | deriv |
| 28 Jun 2021 | CONVERSION | Bright Health Group Inc. | 6,516,356 | 0.00 USD | deriv |
| 28 Jun 2021 | CONVERSION | Bright Health Group Inc. | 8,901,166 | 0.00 USD | deriv |
| 28 Jun 2021 | CONVERSION | Bright Health Group Inc. | 15,619,807 | 0.00 USD | deriv |
| 28 Jun 2021 | CONVERSION | Bright Health Group Inc. | 1,109,284 | 0.00 USD | deriv |
| 28 Jun 2021 | CONVERSION | Monte Rosa Therapeutics, Inc. | 669,002 | — |
1 purchase reported after at least 12 months of silence — most recent on 06 Apr 2018.